STAT Plus: Pharmalittle: FDA to issue guidance on Covid-19 vaccines; what remdesivir pricing may really mean
Gilead Sciences, in a self-described effort to do “the right and responsible thing,” may have just set a precedent its industry peers will come to resent.
Top of the morning to you, and a fine one it is. A shiny sun and cool breezes are enveloping the Pharmalot at 1 p.m. ET to discuss the state of the pharmaceutical industry, such as it is. So turn on and tune in. Meanwhile, have a great day …
